Quest Diagnostics Incorporated stock is up 5.47% since 30 days ago. The dividend yield is 2.14% and its next earnings date is Feb 1, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 73.08% of the previous 26 December’s closed higher than November. In the last 10 Unusual Options Trades, there were 2 PUTs, 8 CALLs. 0% of analysts rate it a buy.
Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
---|---|---|---|---|---|
01 Nov 17:26 | 19 Jan, 2024 | 135.00 | 292 | ||
03 Nov 14:58 | 16 Feb, 2024 | 110.00 | 11 | ||
03 Nov 15:52 | 17 Nov, 2023 | 135.00 | 2658 | ||
03 Nov 19:55 | 17 Nov, 2023 | 130.00 | 2398 | ||
07 Nov 16:56 | 19 Jan, 2024 | 130.00 | 307 | ||
16 Nov 17:00 | 17 Nov, 2023 | 135.00 | 2835 | ||
16 Nov 19:06 | 17 May, 2024 | 155.00 | 2 | ||
27 Nov 16:47 | 16 Feb, 2024 | 140.00 | 132 | ||
27 Nov 16:47 | 16 Feb, 2024 | 140.00 | 132 | ||
28 Nov 19:36 | 19 Jan, 2024 | 140.00 | 25 |
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic info services. It also provides risk assessment services for life insurance industry; and healthcare organizations and clinicians robust information technology solutions.